Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» GW Pharma
GW Pharma
GW's Epidiolex topped sales predictions, but investors bailed. What gives?
Fierce Pharma
Thu, 11/7/19 - 10:13 am
GW Pharma
Epidiolex
GW Pharma's cannabis-derived epilepsy medicine makes the cut in the European Union
Endpoints
Tue, 09/24/19 - 10:59 am
GW Pharma
Europe
Epidyolex
Epidiolex
For GW Pharma CEO Justin Gover, The CBD Trend Started 20 Years Ago
Xconomy
Mon, 08/26/19 - 09:41 am
GW Pharma
Pharma CEOs
Justin Gover
GW confident epilepsy drug will get NHS funding despite NICE rejection
Pharmaforum
Fri, 08/23/19 - 12:08 pm
GW Pharma
UK
NHS
NICE
Epidyolex
epilepsy
5 Things You'll Want to Watch With GW Pharmaceuticals
Motley Fool
Wed, 06/12/19 - 09:41 am
GW Pharma
Epidiolex
Europe
Sativex
regulatory
GW Pharma scores another PhIII win for its cannabinoid in rare form of epilepsy
Endpoints
Mon, 05/6/19 - 07:35 pm
GW Pharma
clinical trials
Epidiolex
cannabindoids
tuberous sclerosis complex
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 04/28/19 - 10:00 pm
Regeneron
Sanofi
Praluent
FDA
Heron Therapeutics
HTX-011
Nabiva
Orchard Therapeutics
Akari Therapeutics
Aldeyra Therapeutics
BioTime
Audentes Therapeutics
Adaptimmune
GW Pharma
Ionis
Biogen
Ovid Therapeutics
TransMedics
IPOs
Trevi Therapeutics
Early Epidiolex sales push up GW Pharma's stock
BioPharma Dive
Wed, 02/27/19 - 10:04 pm
Epidiolex
GW Pharma
epilepsy
Cannabis-Based Drug (Still) Helps Epilepsy, but How Safe Is It?
Motley Fool
Tue, 11/27/18 - 11:27 pm
GW Pharma
Epidiolex
Cannabidiol
clinical trials
Dravet syndrome
GW announces US launch of cannabinoid medicine for seizures
Pharmaceutical Business Review
Fri, 11/2/18 - 11:25 am
GW Pharma
Greenwich. Epidiolex
drug launches
Dravet syndrome
Lennox-Gastaut Syndrome
Why GW Pharmaceuticals Stock Jumped 17.7% in September
Moltey Fool
Sat, 10/6/18 - 12:46 pm
GW Pharma
Epidiolex
GW Pharma looks to dispel cannabis stigma with Epidiolex launch
Fierce Pharma
Fri, 10/5/18 - 08:53 pm
GW Pharma
Epidiolex
drug launches
Cannabidiol
Cannabis-Based Drug Companies Hopeful Epidiolex Will Pave the Way for Future Approvals
BioSpace
Tue, 10/2/18 - 10:47 pm
GW Pharma
FDA
Epidiolex
cannabindoids
GW Pharma, armed with best-case DEA decision, charts path to Epidiolex launch
Fierce Pharma
Thu, 09/27/18 - 12:03 pm
GW Pharma
FDA
Epidiolex
epilepsy
DEA
2 Blockbuster New Drug Launches Making Investors Nervous Right Now
Motley Fool
Sun, 08/26/18 - 12:01 pm
drug launches
Alnylam
GW Pharma
Onpattro
Epidiolex
These Epilepsy Drugmakers Are About to Brawl
Motley Fool
Thu, 07/19/18 - 11:30 pm
epilepsy
Zogenix
ZX008
GW Pharma
Epidiolex
Zogenix Epilepsy Data Sets Up Market Battle With GW’s Cannabis Drug
Xconomy
Thu, 07/12/18 - 09:59 am
Dravet syndrome
clinical trials
Zogenix
ZX008
FenPhen
GW Pharma
Epidiolex
Berkeley boy was ‘Patient X’ in first FDA-approved medicine derived from marijuana
San Francisco Chronicle, CA
Mon, 07/9/18 - 10:01 pm
patients
clinical trials
GW Pharma
Epidiolex
seizures
CBD
CBD Oil Products Were Already Readily Available – How is Epidiolex Different?
CP Wire
Mon, 07/2/18 - 04:56 pm
CBD
Epidiolex
GW Pharma
FDA
CBD Oil Products Were Already Readily Available – How is Epidiolex Different?
Tue, 07/3/18 - 02:05 pm
CBD
Epidiolex
GW Pharma
FDA
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »